# AMPIO PHARMACEUTICALS INC (AMPE)

> Institutional ownership reported to the SEC as of Q1 2026, from Form 13F filings. Source: https://holderbook.com/stocks/AMPE/

- Reporting holders: 1
- Reported value: $67
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Cypress Capital Management LLC (WY)](https://holderbook.com/funds/1633896-cypress-capital-management-llc-wy/) | $67 | 440 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2026 | 1 | $67 |
| Q4 2025 | 1 | $2 |
| Q3 2025 | 1 | $1 |
| Q2 2025 | 1 | $1 |
| Q2 2024 | 3 | $13 |
| Q1 2024 | 28 | $48.6K |
| Q4 2023 | 28 | $720.3K |
| Q3 2023 | 27 | $1.1M |
| Q2 2023 | 37 | $171.1K |
| Q1 2023 | 36 | $195.9K |
| Q4 2022 | 33 | $285.7K |
| Q3 2022 | 83 | $1.8M |